StockWatch
·
Q2 FY-2027 RESULTS · PROSTARM

Prostarm Q2 FY27: consol PAT -27% YoY to ₹6.1 Cr on 82% revenue surge, margins compress

PAT -26.52% YoY · revenue +82.07% · margins compressing

Q2 FY27 resultsPROSTARMProstarm Info Systems Ltd07 Nov 2026 · 3 min read
Revenue

₹120.01 Cr

+82.07% YoY

PAT (consolidated)

₹6.07 Cr

-26.52% YoY

Net margin

4.99%

-7.3pp YoY

EPS

₹1.03

Prostarm Info Systems' consolidated revenue for Q2 FY27 (quarter ended September 30, 2026) came in at ₹120.01 Cr, up a sharp 82.1% year-on-year from ₹65.92 Cr and 57.8% sequentially from ₹76.05 Cr. But profitability moved the other way: consolidated PAT fell 26.5% YoY to ₹6.07 Cr from ₹8.27 Cr, even though it rose 32.6% quarter-on-quarter from ₹4.58 Cr. Read YoY-first, this is a profit decline dressed up in a revenue surge — net margin compressed to roughly 5.1% from 12.3% a year ago. Standalone PAT was ₹6.34 Cr on revenue of ₹119.46 Cr, close to the consolidated number, confirming the three BESS/energy subsidiaries remain immaterial to the group's bottom line for now. No exceptional items appear in either statement, so both YoY figures are reported, like-for-like.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹120.01 Cr+57.8%+82.1%
Expenses₹113.64 Cr+56.9%+101.7%
PAT₹6.07 Cr+32.63%-26.52%
Net margin4.99%-0.8pp-7.3pp
EPS₹1.03+32.1%-33.1%

The margin bridge is visible in the expense lines: purchase of stock-in-trade — a proxy for lower-margin EPC/trading volumes — jumped to ₹95.04 Cr from ₹24.81 Cr a year ago (+283%), while cost of material consumed actually fell (₹15.88 Cr vs ₹20.25 Cr), pointing to a revenue mix shift away from in-house manufacturing toward trading/execution-led business. Finance costs more than doubled to ₹2.04 Cr from ₹0.88 Cr as borrowings rose to fund working capital. The net effect: EBITDA-level margin fell to about 9.3% from 17.0% YoY (versus 8.5% last quarter), and net margin is running well below management's own FY27-end target of 8.5-9% PAT margin and 12-13% EBITDA margin, set out on the August 2026 concall.

₹
114.45123.62132.78141.94151.11136.308-0408-2609-1810-1311-0511-06
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹136.3, up 3.8% over the past month of trading.

₹ Cr
05.5711.1316.71.83Q1 FY26rev ₹55 Cr8.27Q2 FY26rev ₹66 Cr14.91Q3 FY26rev ₹160 Cr7.95Q4 FY26rev ₹104 Cr4.58Q1 FY27rev ₹76 Cr6.07Q2 FY27rev ₹120 Cr
Quarterly consolidated PAT, ₹ Crore
What management guided (1 FY-2027 call)
FY27 targets minimum 25% revenue growth (maintained). EBITDA margins 12–13% by year-end, PAT margins 8.5–9% (upper end cut from prior 9.5%). Working capital to reach 120–150 days by March 2027; operating cash flow expected positive by FY27-end.

— This quarter: missed

On revenue, the company remains comfortably ahead of its guided 'minimum 25% growth' for FY27 — H1 FY27 consolidated revenue is up 62.2% YoY to ₹196.06 Cr — but on margins it is tracking well short of plan with two quarters left in the year. There is no sell-side consensus on record for Prostarm (no analyst coverage found), so vs-street is unknown; this read is benchmarked only against the company's own prior guidance. H1 FY27 operating cash flow was negative ₹17.77 Cr (versus negative ₹12.74 Cr in H1 FY26) as inventory and receivables continue to build, running counter to management's stated goal of positive operating cash flow by FY27-end and its 120-150 day working-capital target for March 2027. The quarter's corporate actions — a ₹42.61 Cr preferential warrant allotment (28.98 lakh warrants) completed in October 2026 after BSE/NSE approvals, alongside cancellation of a BESS project MoU in September 2026 — show capital being raised even as working capital stays stretched; no press release accompanied this result to corroborate management's own framing.

  • W1

    EBITDA margin needs to rise from ~9.3% (Q2 FY27) to management's guided 12-13% by FY27-end — watch H2 trajectory.

  • W2

    PAT margin needs to climb from ~5.1% to the guided 8.5-9% band by March 2027.

  • W3

    Operating cash flow guided positive by FY27-end versus a ₹17.77 Cr negative H1 FY27 print — watch working-capital days against the 120-150 day target.

Informational and educational content only. Not investment advice.